Hybrid molecules based on caffeic acid as potential therapeutics: A focused review

X Zhao, Z Liu, H Liu, J Guo, S Long - European Journal of Medicinal …, 2022 - Elsevier
Caffeic acid-based compounds possess a high degree of structural diversity and show a
variety of pharmacological properties, providing a useful framework for the discovery of new …

[HTML][HTML] Cyclooxygenase-2 (COX-2) as a target of anticancer agents: A review of novel synthesized scaffolds having anticancer and COX-2 inhibitory potentialities

NUA Mohsin, S Aslam, M Ahmad, M Irfan… - Pharmaceuticals, 2022 - mdpi.com
Cancer is a serious threat to human beings and is the second-largest cause of death all over
the globe. Chemotherapy is one of the most common treatments for cancer; however, drug …

New Insights Into the Anticancer Effects of p-Coumaric Acid: Focus on Colorectal Cancer

W Tehami, A Nani, NA Khan, A Hichami - Dose-Response, 2023 - journals.sagepub.com
Colorectal cancer is considered the second most deadly cancer in the world. Studies have
indicated that diet can prevent the risk of developing colorectal cancer. Recently, there has …

[HTML][HTML] Optimization of pyrazolo [1, 5-a] pyrimidine based compounds with pyridine scaffold: Synthesis, biological evaluation and molecular modeling study

MA Abdelgawad, NAA Elkanzi, A Musa… - Arabian Journal of …, 2022 - Elsevier
Background Pyrazolopyrimidine heterocycle and its isosteres represent the main scaffold for
many pharmacologically active drugs including anti-inflammatory agents. The COX-2 …

Green Design, Synthesis, and Molecular Docking Study of Novel Quinoxaline Derivatives with Insecticidal Potential against Aphis craccivora

MA Alanazi, WAA Arafa, IO Althobaiti, HA Altaleb… - ACS …, 2022 - ACS Publications
An efficient and environmentally friendly method was established for designing novel 3-
amino-1, 4-dihydroquinoxaline-2-carbonitrile (1) via the reaction of bromomalononitrile and …

Small-molecule drugs of colorectal cancer: Current status and future directions

Y Yang, P Liu, M Zhou, L Yin, M Wang, T Liu… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the world's
fourth most deadly cancer. CRC, as a genetic susceptible disease, faces significant …

Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review

C Wang, Y Zhang, T Zhang, J Xu, S Yan, B Liang… - International Journal of …, 2023 - Elsevier
Overexpression of the epidermal growth factor receptor (EGFR) has been linked to several
human cancers, including esophageal cancer, pancreatic cancer, anal cancer, breast …

[HTML][HTML] EGFR and COX-2 dual inhibitor: the design, synthesis, and biological evaluation of novel chalcones

A Musa, EM Mostafa, SNA Bukhari, NH Alotaibi… - Molecules, 2022 - mdpi.com
For most researchers, discovering new anticancer drugs to avoid the adverse effects of
current ones, to improve therapeutic benefits and to reduce resistance is essential. Because …

Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) …

M Rudrapal, KK Kirboga, M Abdalla, S Maji - Molecular Diversity, 2024 - Springer
Abstract Cyclooxygenase-2 (COX-2) inhibitors are nonsteroidal anti-inflammatory drugs that
treat inflammation, pain and fever. This study determined the interaction mechanisms of …

[HTML][HTML] Modulating effects of zingiberaceae phenolic compounds on neurotrophic factors and their potential as neuroprotectants in brain disorders and age …

AM Razak, JK Tan, M Mohd Said, S Makpol - Nutrients, 2023 - mdpi.com
The Zingiberaceae family possess various phenolic compounds that have significant
systemic bioactivities in the brain, including in age-related neurodegenerative diseases …